Cargando…

Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer’s disease

BACKGROUND: The spread of tau pathology in Alzheimer’s disease (AD) is mediated by cell-to-cell transmission of pathological tau seeds released from neurons that, upon internalization by recipient neurons, template the misfolding of naïve cellular tau, thereby propagating fibrillization. We hypothes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gibbons, Garrett S., Kim, Soo-Jung, Wu, Qihui, Riddle, Dawn M., Leight, Susan N., Changolkar, Lakshmi, Xu, Hong, Meymand, Emily S., O’Reilly, Mia, Zhang, Bin, Brunden, Kurt R., Trojanowski, John Q., Lee, Virginia M. Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643305/ https://www.ncbi.nlm.nih.gov/pubmed/33148293 http://dx.doi.org/10.1186/s13024-020-00404-5

Ejemplares similares

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)
por: Gibbons, Garrett S., et al.
Publicado: (2019)

In vitro amplification of pathogenic tau conserves disease-specific bioactive characteristics
por: Xu, Hong, et al.
Publicado: (2021)

Inhibition of CK2 mitigates Alzheimer’s tau pathology by preventing NR2B synaptic mislocalization
por: Marshall, Courtney A., et al.
Publicado: (2022)

Unique pathological tau conformers from Alzheimer’s brains transmit tau pathology in nontransgenic mice
por: Guo, Jing L., et al.
Publicado: (2016)

Human tau pathology transmits glial tau aggregates in the absence of neuronal tau
por: Narasimhan, Sneha, et al.
Publicado: (2019)

LRRK2 Kinase Activity Does Not Alter Cell-Autonomous Tau Pathology Development in Primary Neurons
por: Henderson, Michael X., et al.
Publicado: (2021)

Identification of small molecules and related targets that modulate tau pathology in a seeded primary neuron model
por: Gibbons, Garrett S., et al.
Publicado: (2023)

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies
por: Trojanowski, John Q
Publicado: (2013)

α-Synuclein modulates tau spreading in mouse brains
por: Bassil, Fares, et al.
Publicado: (2020)

Fluent molecular mixing of Tau isoforms in Alzheimer’s disease neurofibrillary tangles
por: Dregni, Aurelio J., et al.
Publicado: (2022)

Effects of microglial depletion and TREM2 deficiency on Aβ plaque burden and neuritic plaque tau pathology in 5XFAD mice
por: Delizannis, Argyro Thalia, et al.
Publicado: (2021)

Tau immunotherapy is associated with glial responses in FTLD-tau
por: Kim, Boram, et al.
Publicado: (2021)

Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
por: Henderson, Michael X., et al.
Publicado: (2019)

Plasma tau in Alzheimer disease
por: Mattsson, Niklas, et al.
Publicado: (2016)

Evaluation of the brain-penetrant microtubule-stabilizing agent, dictyostatin, in the PS19 tau transgenic mouse model of tauopathy
por: Makani, Vishruti, et al.
Publicado: (2016)

Computational modeling of tau pathology spread reveals patterns of regional vulnerability and the impact of a genetic risk factor
por: Cornblath, Eli J., et al.
Publicado: (2021)

In vitro generation of tau aggregates conformationally distinct from parent tau seeds of Alzheimer’s brain
por: Nam, Won-Hee, et al.
Publicado: (2018)

A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model
por: Zhang, Bin, et al.
Publicado: (2018)

Passive Immunization with Phospho-Tau Antibodies Reduces Tau Pathology and Functional Deficits in Two Distinct Mouse Tauopathy Models
por: Sankaranarayanan, Sethu, et al.
Publicado: (2015)

Pathological conformations involving the amino terminus of tau occur early in Alzheimer’s disease and are differentially detected by monoclonal antibodies
por: Combs, Benjamin, et al.
Publicado: (2016)

Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer’s disease model
por: Goñi, Fernando, et al.
Publicado: (2018)

Astroglial tau pathology alone preferentially concentrates at sulcal depths in chronic traumatic encephalopathy neuropathologic change
por: Arena, John D, et al.
Publicado: (2020)

PIKfyve activity is required for lysosomal trafficking of tau aggregates and tau seeding
por: Soares, Alberto Carpinteiro, et al.
Publicado: (2021)

TFEB enhances astroglial uptake of extracellular tau species and reduces tau spreading
por: Martini-Stoica, Heidi, et al.
Publicado: (2018)

Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease
por: Kraus, Allison, et al.
Publicado: (2018)

Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease
por: Fossati, Silvia, et al.
Publicado: (2019)

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
por: Bakota, Lidia, et al.
Publicado: (2016)

Microglial internalization and degradation of pathological tau is enhanced by an anti-tau monoclonal antibody
por: Luo, Wenjie, et al.
Publicado: (2015)

Evolving prion-like tau conformers differentially alter postsynaptic proteins in neurons inoculated with distinct isolates of Alzheimer’s disease tau
por: Hromadkova, Lenka, et al.
Publicado: (2023)

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease
por: Lau, Dawn H. W., et al.
Publicado: (2016)

Signature of an aggregation-prone conformation of tau
por: Eschmann, Neil A., et al.
Publicado: (2017)

Toxic tau: structural origins of tau aggregation in Alzheimer's disease
por: Mamun, Abdullah Al, et al.
Publicado: (2020)

Predicting clinical decline and conversion to Alzheimer’s disease or dementia using novel Elecsys Aβ(1–42), pTau and tTau CSF immunoassays
por: Blennow, Kaj, et al.
Publicado: (2019)

Acetylation of Tau Induces Alzheimer's Disease-Associated Tau in Transgenic Mice
por: Ali, Addison, et al.
Publicado: (2021)

Acetylation of Tau Induces Alzheimer's Disease-Associated Tau in Transgenic Mice
por: Ali, Addison, et al.
Publicado: (2021)

Cellular Biology of Tau Diversity and Pathogenic Conformers
por: Kang, Sang-Gyun, et al.
Publicado: (2020)

Tau Ubiquitination in Alzheimer's Disease
por: Li, Longfei, et al.
Publicado: (2022)

Tau kinetics in Alzheimer's disease
por: Hier, Daniel B., et al.
Publicado: (2022)

Novel monoclonal antibodies to normal and pathologically altered human TDP-43 proteins
por: Kwong, Linda K, et al.
Publicado: (2014)

Elevated CSF GAP-43 is Alzheimer’s disease specific and associated with tau and amyloid pathology
por: Sandelius, Åsa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_u1pj4jbch928t0102tj6ortcud